Clinical Trial Update: GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial update reports results of GCAR1, a GPNMB-targeting CAR-T cell therapy, in a patient with alveolar soft part sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma

Drugs mentioned

• GCAR1

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Alveolar Soft Part Sarcoma | EARLY_Phase 1 | Status: COMPLETED